Mycoplasma Diagnostics Market 2016 Share, Trend and Forecast Mycoplasma Diagnostics Market - Global Industry An

Mycoplasma
Diagnostics
Market
-
Global
Industry Analysis, Size, Share, Growth, Trends
and Forecast 2016 - 2024
Global Mycoplasma Diagnostics Market: Snapshot
Mycoplasma diagnostics is a class of medical tests or examination conducted to
evaluate nucleic acids or proteins at a molecular level. This aids in the early
detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is
considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic
industry. Usually, usage of molecular diagnostics was limited due to necessity of
vastly skilled specialists and high cost of tests. But decline in cost per sample
analysis and labor cost, improvements in automation and introduction of advanced
technologies has extended the usage of molecular diagnostics in wide range of
applications. The market for mycoplasma diagnostics has expanded since 1990’s
with the introduction of PCR. It is estimated that in the U.S. over 600 laboratories
and 200 independent laboratories perform mycoplasma diagnostics test to simplify
and accelerate the testing process.
The global mycoplasma diagnostics market, which stood at US$602.0 mn in 2016, is
forecast to reach US$1.35 bn by the end of 2024. If these figures hold true, the
market will exhibit a CAGR of 10.6% between 2016 and 2024.
View Report @ http://www.transparencymarketresearch.com/mycoplasma-
diagnostics-market.html
Demand for Software & Services Projected to Increase at High Pace
Based on product, the global mycoplasma diagnostics market can be segmented
into kits & reagents, instruments, and software & services. Of these, the kits &
reagents segment dominated the market in 2016 and is expected to hold on to its
lead through the forecast period. However, growth witnessed in the software &
services segment is forecast to be higher in the coming years. The rising demand
for automation in pharma, dianostics, and clinical sectors to realize the benefits of
cost-effectiveness, will fuel application of mycoplasma diagnostics in these
applications.
By technology, PCR, immunoassay, DNA staining, microbial culture techniques and
others are the key market segments. Currently, the PCR segment contributes the
largest share in the revenue generated by the market based on technology. The